05/31/2017 - 8:37am

Walgreens Boots Alliance is likely to litigate should the Federal Trade Commission sue to block its proposed merger of Rite Aid, Cowen analyst Charles Rhyee opined according to a StreetInsider.com report published Wednesday. Rite Aid's value "remains significant" Rhyee noted. "This leads us to believe if the FTC were to block, WBA would litigate to win Rite Aid," he said. A deadlocked FTC is also a possibility, according to Rhyee. "The FTC Chairman, Maureen Ohlhausen, who is likely more favorable to the transaction, could use the 1-1 vote as leverage to build consensus and arrive at a consent decree." (StreetInsider.com)

05/18/2017 - 11:08am

Coming from a diverse neighborhood gave her ‘street smarts,’ but Rite Aid’s head of pharmacy tells Drug Store News her most important leadership lessons came from two pillars of the Philadelphia community — her mom and dad.

05/17/2017 - 2:40pm

Sales of artificial eyelashes packaged with adhesives rose 31% to $157 million, according to IRI data for multi-outlet retailers for the 52-week period ended March 19. Eyelash adhesives kicked in another $30 million and showed growth of 24%.

05/16/2017 - 11:03am

Continued Civil Information Demands from the Federal Trade Commission may be indicative that the agency plans to block the proposed merger, according to The New York Post sources.

05/09/2017 - 5:41am

The two companies have certified substantial compliance with the Federal Trade Commission — a move that will leave the chains free to merge if the FTC hasn’t issued a decision before July 7.

05/04/2017 - 10:52am

Four key customer-centric programs that are critical to Rite Aid include its immunization program, medication synchronization, a differentiated loyalty card offeing and a contemporary store format.

05/04/2017 - 9:54am

As part of its merger agreement with Walgreens Boots Alliance, Rite Aid's agreement to sell 865  stores and certain specified assets to Fred's Pharmacy may expand to as many as 1,200 locations.

05/01/2017 - 2:21pm

Once implemented, the FTC will have 90 days to either clear the $9.7 billion deal, or sue to block it, reported the news outlet.

05/01/2017 - 10:16am

According to a report in TheStreet published Monday, CNBC "Mad Money" host Jim Cramer advised Walgreens shareholders to hold on to what they have, because no matter how the Rite Aid deal pans out, Walgreens will win. "If the deal's derailed by the FTC, I think we're going to get a truly monster buyback," Cramer said during an exclusive monthly conference call for members of his Action Alert Plus investment club. "If the deal is accepted, analysts can raise their numbers substantially. Those are good outcomes." (TheStreet)